Filing Details

Accession Number:
0001209191-22-053691
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-10-14 17:41:14
Reporting Period:
2022-10-14
Accepted Time:
2022-10-14 17:41:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1697532 Applied Therapeutics Inc. APLT Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1775490 Shoshana Shendelman C/O Applied Therapeutics, Inc.
545 Fifth Avenue, Suite 1400
New York NY 10017
President And Ceo Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-10-14 50,000 $0.65 767,495 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,750,000 Indirect See footnote
Common Stock 1,492,094 Indirect See footnote
Common Stock 709,720 Indirect See footnote
Common Stock 290,280 Indirect See footnote
Common Stock 88,397 Indirect See footnote
Footnotes
  1. These shares were purchased by Dr. Shendelman in multiple transactions.
  2. Weighted average price. These shares were purchased by Dr. Shendelman in multiple transactions at prices ranging from $0.6005 to $0.665 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
  3. Through a grantor retained annuity trust.
  4. Through a family trust controlled by the reporting person's spouse.
  5. Through the reporting person's spouse.
  6. Through a family trust controlled by the reporting person.
  7. Through Clearpoint Strategy Group LLC of which the reporting person is the sole owner.